Immune Monitoring Core

$115,719U19FY2013AINIH

Beth Israel Deaconess Medical Center, Boston MA

Investigators

Linked publications & trials

Paper 37811993 Paper 30629920 Paper 30575753 Paper 30283138 Paper 30249811 Paper 30047376 Paper 29669026 Paper 29643249 Paper 29606355 Paper 29563285 Paper 29514912 Paper 29321310 Paper 29298888 Paper 29237759 Paper 28931655 Paper 28931639 Paper 28878010 Paper 28768869 Paper 28580942 Paper 28539448 Paper 28457610 Paper 28239679 Paper 28228277 Paper 28133810 Paper 27899229 Paper 27841870 Paper 27566899 Paper 27540005 Paper 27492477 Paper 27448585 Paper 27419172 Paper 27355570 Paper 27268856 Paper 27085913 Paper 27010970 Paper 26982805 Paper 26962943 Paper 26865713 Paper 26849216 Paper 26379068 Paper 26376928 Paper 26193080 Paper 26138104 Paper 26116499 Paper 25910199 Paper 25540368 Paper 25523925 Paper 25473043 Paper 25445329 Paper 25424923 Paper 25416935 Paper 25410856 Paper 25296195 Paper 25210178 Paper 25165165 Paper 25042999 Paper 25013067 Paper 24991003 Paper 24965452 Paper 24820481 Paper 24778441 Paper 24719474 Paper 24648461 Paper 24556505 Paper 24429370 Paper 24316643 Paper 24283223 Paper 24257612 Paper 24243013 Paper 24172905 Paper 23925001 Paper 23772627 Paper 23408608 Paper 23388715 Paper 23221002 Paper 23175355 Paper 23152535 Paper 23125444 Paper 23125443 Paper 22787208

Abstract

PROJECT SUMMARY (See instructions): Standardized assessments of binding, neutralization, ADCC, and ADCVl effector activities of antibodies elicited by candidate HlV-1 Env immunogens are critical for informing HIV-1 vaccine design. Core B (Immune Monitoring Core) will provide standardized and validated GCLP humoral immune monitoring assay services for evaluating antibody responses elicited by Ad26/Ad26 and A26/MVA vector regimens with and without an Env gp140 trimer protein boost. We further propose to utilize additional assays for mapping the epitope specificities of NAb generated by these unique vaccine regimens. These services will provide critical support for Projects 1 and 2 by providing data that will help guide immunogen design and strategies for vaccine formulation and delivery.! We propose the following Specific Aims for Core B: 1. We will assess Env-specific antibody responses in subjects immunized with candidate HlV-1 Env immunogens for binding, neutralization, ADCC, and ADCVl effector activities. 2. We will utilize multiple assay formats for mapping the epitope specificities of antibodies elicited by vaccine regimens tested in Projects 1 and 2.

View original record on NIH RePORTER →